Monthly Archives: March 2020

Online Medical Cannabis Video Consultations

Online Video Consultations

Dear patients,

We know this is not an easy time for anyone. Please be clear, our services are running as normal, with no disruption to clinical consultations or the supply of cannabis medicines.

From today our specialist doctors will be able to meet with you for your consultation via online video link. There is NO need to visit our clinics.

For information on appointments already scheduled, or if you require a new appointment please email:

If you require information about medicine delivery timelines, please email the pharmacy, For all other enquiries, please call the clinics on 0203 928 2813.

Wishing you and your loved ones well,
The Medical Cannabis Clinics

Medical Cannabis Patient Access Programme

Launching our low cost patient access programme

The Medical Cannabis Clinics (TMCC), has today launched a patient registry for up to 5,000 patients. The launch follows a recent policy change allowing bulk supply to be imported and held in the UK.

The TMCC Access Programme will deliver:

  • a reliable and quicker route for patients to access their medicines
  • reduced clinician consultancy fees, and
  • standardised, low-cost prescription plans

The registry will collect real world data so that a body of evidence of quality-of-life and other patient related outcomes can be collected and provided to government groups and the NHS. This will give further reassurance of safety and efficacy when patients use medical cannabis. Patients will finally see the speed of delivery and consistency of medicines along with the realistic pricing that is to be expected, while recording critical data that will help secure an eventual NHS pathway for patients.

Hannah Deacon, mother of child epilepsy sufferer, Alfie Dingley, and long term patient advocate, said:

“It’s been a year since the rescheduling and I see first-hand that there remains a lot of families unnecessarily suffering. The recent change permitting bulk imports is an important step but there is still a long road ahead. This initiative by The Medical Cannabis Clinics will offer many patients a lifeline by making it substantially easier, quicker and vastly reducing the costs.”

According to a recently published YouGov poll 1.4 million Britons are using street cannabis to treat chronic and medically-diagnosed conditions, which demonstrates the extraordinary lengths patients are having to go to, when many of these patients should be receiving medical cannabis through the legal medical channels.

Speaking about the launch of the new patient access programme, Chief Medical Officer, Prof. Mike Barnes said:

“The TMCC Access Programme breaks down one of the biggest hurdles for patients in getting access to affordable, safe treatments prescribed to patients by experts in a clinical and legal setting.”

Prof. Barnes added:

“The collection of a body of data is of critical importance in building up the data points necessary to demonstrate the efficacy of medical cannabis for a multitude of conditions.”

Gathering of real world data on patients will be anonymised, and there will be a focus on patients suffering with: spasticity, pain, anxiety, or with neurological conditions. Whether the patient is entitled to a prescription will be down to the discretion of the patient’s clinician. In order to be approved for the registry, patients can sign up now by visiting here.


Medical Cannabis & PTSD

PTSD is a term that started being used in the 1970s, although it was first listed in the third edition of the DSM in 1980. The inclusion of the term within the manual is largely thought to be due to the increased awareness around the mental issues Vietnam war veterans were experiencing following their service.

PTSD is not just experienced by veterans though. It can be experienced by anyone who has experienced a highly affecting and traumatic event. In fact, the NHS estimates that PTSD affects as many as 1 in every 3 people who have a traumatic experience.

So what is PTSD?

The term itself refers to post-traumatic stress disorder – a trauma and stressor related disorder (as listed in the fifth edition of the DSM) where a patient exhibits a prolonged response to a traumatic experience, resulting in a number of disabling symptoms.

Symptoms may include:

● Extreme physical reactions to reminders of the trauma – for instance nausea, sweating and a pounding heart
● Insomnia
● Difficulty concentrating
● Upsetting and invasive memories of the traumatic event
● Flashbacks
● A feeling of numbness or detachment from other people and the world around you
● A loss of interest in daily activities and activities you used to enjoy
● Intense feelings of distress when reminded of the traumatic event
● Avoidance of anything (e.g. activities or places) that reminds you of the event

These symptoms can ultimately make everyday life much harder for sufferers, with the need to avoid triggering circumstances limiting the individual’s ability to carry out tasks as they normally would prior to the traumatic event.

It’s important to note that PTSD might not present itself straight away. While some may experience the debilitating effects of the disorder immediately after their traumatic experience, many may not develop the disorder for weeks or years following the event.

While it’s normal for people to experience symptoms of PTSD for a short while following a disturbing experience, if these symptoms persist for more than 4 weeks following the event, then GPs should be contacted. If necessary, the GP can then refer the PTSD affected patient onto a mental health specialist so that their condition can be continually assessed and the correct form of treatment can be offered to them.
Typical treatment routes for PTSD

Some common first-line treatment options for PTSD include:

● Watchful waiting – where patients are encouraged to monitor their symptoms to see if they improve over time without the need for more intense treatment options
● Psychological therapies – like cognitive behavioural therapy (CBT)
● Eye movement desensitisation and reprocessing – a relatively new form of treatment that involves patients making rhythmic eye movements whilst picturing the event that triggered their symptoms. This supposedly allows the patient to work through their traumatic memories properly as the rapid eye movements are believed to mimic the way the brain processes memories during sleep.
● The use of antidepressants

How might cannabis help?

It is thought that medical cannabis generally, and THC and CBD more specifically, may be able to help those suffering from PTSD as the endocannabinoid system is believed to play a role in mediating our memory retrieval and consolidation processes. The use of cannabinoids may therefore impact the recall of traumatic memories associated with the event in question.

THC, as it thought to diminish the amount of time in REM sleep, may play a role in lessening the amount of nightmares experienced by sufferers regarding the traumatic event they may have experienced. When you couple this theorisation with the fact that THC is known to induce drowsiness, it’s thought that the use of THC-heavy medicines may allow sufferers to address the nightmares and insomnia associated with the disorder simultaneously.

Additionally, coexisting conditions of PTSD like feelings of anxiety and distress may be able to be treated with medical cannabis, as the activation of CB1 and CB2 receptors is thought to trigger the system’s ability to produce neurotransmitters that lead to an increased sense of happiness and pleasure.

This ability to create a greater sense of overall well-being while addressing specific symptoms of the disorder like nightmares and insomnia makes cannabis an exciting potential form of treatment for the disorder, although it is acknowledged that more research is required in this area to bolster the existing findings around cannabis’ efficacy for this indication.

To find out more about the psychiatric conditions we can treat with medical cannabis at our clinics, click here.

We only recommend taking cannabis-based products following a consultation with a medical professional, and do not advise patients on the recreational use of any cannabis-based products.

At The Medical Cannabis Clinics, our GMC registered specialists will identify the appropriate cannabis medicine care plan and products for patients following a comprehensive assessment which includes an in-depth evaluation of the main symptoms being targeted, current medications, pattern of symptoms and lifestyle factors such as safety-sensitive occupations.

They will also monitor and adjust the medication on a regular basis to ensure the best effect with the fewest side effects. There is also a carefully designed process in place to monitor patients’ wellbeing, with follow-up appointments after a week and then every month, for three months after receiving a prescription.